Corvus Pharmaceuticals Inc (CRVS)

Corvus Pharmaceuticals Inc (CRVS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $876M; returns 1 day -1.1%, 1 week +10.6%, 1 year +47.1%.

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that does not currently generate revenue from product sales. Its business model is entirely focused on the research and development of novel immunotherapies for cancer and immune-mediated diseases. The company's operations are funded through equity financing and strategic partnerships.

Groups CRVS belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Biopharmaceutical
• Immunotherapy
• Oncology
• Cancer Therapeutics
• Autoimmune Diseases
• Chronic Inflammatory Diseases
• R&D

CRVS financial model: income statement, cash flow and balance sheet